Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patientMarket Segmentation Analysis
Review of nine 2024-2029 POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market segment:
- Physician Offices/Group Practices;
- Emergency Rooms
- Operating/Recovery Suites
- ICUs/CCUs
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers
Sales and Market Share Analysis
- Sales and market shares of major coagulation reagent and instrument suppliers.
Current and Emerging Products
- Analysis of coagulation procedures performed in 2024-2029 POC testing locations.
Technology Review
- Emerging technologies and their applications for 2024-2029 POC testing.
- Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.
Competitive Assessments
- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
- Specific opportunities for new coagulation instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for 2024-2029 POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.